Search - tctmd.com

Displaying 181 - 200 of 238

Sort: Relevancy | Date

Presentation TCT 2013

Synthesis of Clinical Trials with the Biomatrix Stent

Presenter: Stephan Windecker

October 28, 2013

News Conference News TCT 2013

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

October 28, 2013

Presentation TCT 2013

YES - Already Common Practice and Justified

Presenter: Stephan Windecker

October 27, 2013

Presentation TCT 2013

The Osiro Stent and BIOFLOW II Studies

Presenter: Stephan Windecker

October 27, 2013

Presentation TCT 2013

Based on the Current Data, Bioabsorbable Polymer DES Offer Late Clinical Advantages!

Presenter: Stephan Windecker

October 27, 2013

News Conference News ESC 2013

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Yael L. Maxwell

September 01, 2013

News Industry News

Positive Patient Outcomes at One Year With Edwards Sapien XT Transcatheter Valve

May 21, 2013

News Daily News

La FA, Preexistente o No, Aumenta la Mortalidad en Pacientes sometidos a TAVR

Jason Kahn

February 11, 2013

News Daily News

A-fib—Whether New or Preexisting—Raises Mortality in Patients Undergoing TAVR

Jason Kahn

February 11, 2013

Presentation TCT 2013

Gender-based Analysis of Everolimus-Eluting Stent Safety in the Bern-Rotterdam Cohort

Presenter: Giulio Stefanini, Lorenz R?ber, Michael Magro, Bindu Kalesan, Masanori Taniwaki, Cihan Simsek, Peter Wenaweser, Ron Van Domburg, Bernhard Meier, Peter Juni, Patrick Serruys, Stephan Windecker

January 31, 2013

Presentation TCT 2013

Gender Differences in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation

Presenter: Stefan Stortecky, Peter Wenaweser, Thomas Pilgrim, Alexander Kadner, Lutz Buellesfeld, Christoph Huber, Ahmed Khattab, Stephan Windecker

January 31, 2013

Presentation TCT 2013

Two Year Outcomes Following Implantation of the Resolute Zotarolimus-eluting Stent in Vessels ?2.5 mm Diameter

Presenter: Ronald Caputo, Martin Leon, Patrick Serruys, Franz-Josef Neumann, Alan Yeung, Stephan Windecker, Jorge Belardi, Sigmund Silber, Ian Meredith, Petr Widimsky, Shigeru Saito, Laura Mauri

January 31, 2013

Presentation TCT 2013

The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated With The Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and Paclitaxel-Eluting...

Presenter: Aris Moschovitis, Giulio Stefanini, Michael Magro, Lorenz R?ber, Bindu Kalesan, Masanori Taniwaki, Joost Daemen, Peter Wenaweser, Ron Van Domburg, Bernhard Meier, Peter Juni, Patrick Serruys, Stephan Windecker

January 31, 2013

Presentation TCT 2013

Impact Of Stent Overlap On Long-Term Clinical Outcomes In Patients Treated With Newer-Generation Drug-Eluting Stents

Presenter: Crochan O'Sullivan, Crochan O'Sullivan, Giulio Stefanini, Lorenz R?ber, Dik Heg, Masanori Taniwaki, Bindu Kalesan, Thomas Pilgrim, Thomas Zanchin, Aris Moschovitis, Lutz B?llesfeld, Ahmed Khattab, Peter Wenaweser, Bernhard Meier, Peter Juni, Stephan Windecker

January 31, 2013

Presentation TCT 2013

Frequency and Type of Neoatherosclerosis Five Years After Drug-Eluting Stent Implantation: an Optical Coherence Tomography Study

Presenter: Masanori Taniwaki, Lorenz R?ber, Sandro Baumgartner, Thomas Pilgrim, Aris Moschovitis, Peter Wenaweser, Bernhard Meier, Stephan Windecker

January 31, 2013

News Daily News

Presentation TCT 2012

PC Trial Recap

Presenter: Stephan Windecker

October 26, 2012

Presentation TCT 2012

The PC Trial: A Prospective, Randomized Trial of PFO Closure vs. Medical Therapy in Patients with Cryptogenic Embolism

Presenter: Stephan Windecker

October 25, 2012

Advertisement

Synthesis of Clinical Trials with the Biomatrix Stent

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

YES - Already Common Practice and Justified

The Osiro Stent and BIOFLOW II Studies

Based on the Current Data, Bioabsorbable Polymer DES Offer Late Clinical Advantages!

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Positive Patient Outcomes at One Year With Edwards Sapien XT Transcatheter Valve

La FA, Preexistente o No, Aumenta la Mortalidad en Pacientes sometidos a TAVR

A-fib—Whether New or Preexisting—Raises Mortality in Patients Undergoing TAVR

Gender-based Analysis of Everolimus-Eluting Stent Safety in the Bern-Rotterdam Cohort

Gender Differences in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation

Two Year Outcomes Following Implantation of the Resolute Zotarolimus-eluting Stent in Vessels ?2.5 mm Diameter

The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated With The Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and Paclitaxel-Eluting...

Impact Of Stent Overlap On Long-Term Clinical Outcomes In Patients Treated With Newer-Generation Drug-Eluting Stents

Frequency and Type of Neoatherosclerosis Five Years After Drug-Eluting Stent Implantation: an Optical Coherence Tomography Study

Un IMC Bajo Predice los ACV y la Muerte tras una TAVR

Low BMI Predicts Stroke, Death After TAVR

PC Trial: Additional Findings

PC Trial Recap

The PC Trial: A Prospective, Randomized Trial of PFO Closure vs. Medical Therapy in Patients with Cryptogenic Embolism

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content